TCT 536: Clinical Impact of Anti-platelet Therapy for Puncture Site Occlusion following Distal Radial Artery Approach

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker’s Bureau - Medtronic; W.L. Gore & Associates; Kaneka Medics; Terumo Medical Corporation; Bard Medical